Search

  • Search

    Negotiated Procedure for the Oncotype-Dx test for breast cancer patients

    Climate Action Authority

    Negotiated Procedure for the Oncotype-Dx test for breast cancer patients

    1. Result notice published

      Feb 12, 7:45 AMFebruary 12, 2024 7:45 AM

    2. Questions deadline

      Jan 20, 11:00 AMJanuary 20, 2026 11:00 AM

    3. Tender submission deadline

      Feb 3, 11:00 AMFebruary 3, 2026 11:00 AM

    4. Contract start date

      Apr 30, 10:00 PMApril 30, 2026 10:00 PM

    5. Tender validity period

      May 3, 10:00 AMMay 3, 2026 10:00 AM

    Brief

    Malta: Tenders/Climate Action Authority/Negotiated Procedure for the Oncotype-Dx test for breast cancer patients

    Awarded

    The competition has ended and a winner has been selected.

    Brief

    Negotiated Procedure for the Oncotype-Dx test for breast cancer patients

    Result

    Winner
    The BioArte Limited
    Number of bids
    0
    Contract value
    €420,000

    About the bid

      Negotiated Procedure for the Oncotype-Dx test for breast cancer patients

      Contact phone
      +356 25404000
      Contact email
      info.cpsu@gov.mt
      Address
      Millenia, Aldo Moro Road,, MRS9065 Marsa

    Custom Assessment Criteria

    Start a free trial to ask your own questions about the tender and get AI-generated answers.

    Award Criteria

    Qualification requirements

      Found no qualification requirements in the contract notice.

    Previous Contract Winners

    Start a free trial to see who has won similar tenders for this buyer.

    See the full notice

    Contracting authority
    Climate Action Authority
    Title
    Negotiated Procedure for the Oncotype-Dx test for breast cancer patients
    Type
    ResultPrequalification
    Main code
    33000000Medical equipments, pharmaceuticals and personal care products
    Supplemental codes

    No supplemental codes from buyer…

    Estimated value
    €420,000.00

    Active similar competitions

    • European Commission, INTPA - International Partnerships

      Medisinsk og laboratorieutstyr

      Supply of equipment for cancer prevention and screening and for neonatal care

      Европската комисија, INTPA - Меѓународни партнерства, има потреба од набавка, испорака, истовар, поставување и инсталација, пуштање во работа, тестирање, обука и одржување за време на гарантниот период на медицинска опрема поделена на три дела: скрининг за рак на дојка; PAC систем за рак на дојка; и неонатална нега. Договорот е со времетраење од 210 дена. Критериумот за доделување е цена (100%).

      CompetitionSep 8, 2026
      Oct 30, 2026(19 days)

    • Health centre Sveti Nikole

      Medisinsk bildebehandlingsutstyr

      procurement of Digital 2D Mammograph

      Health centre Sveti Nikole needs a Digital 2D Mammograph for the needs of the Health Centre Sveti Nikole, with a maximum total value of 187,000 EUR. The contract duration is 365 days. The award criterion is the lowest price.

      CompetitionSep 30, 2026
      Oct 15, 2026(4 days)
      €187,000

    • Sykehusinnkjøp Hf

      Medisinsk engroshandel

      2707 Onkologi

      Sykehusinnkjøp HF planlegger anskaffelsen av legemidler til behandling av kreft på vegne av de fire regionale helseforetakene i Norge. Leverandører inviteres til å melde sin interesse for dialogmøter via kommunikasjonsmodulen i Ivalua.

      PlanningAug 26, 2026
      Dec 26, 2026(76 days)

    • WIELKOPOLSKIE CENTRUM ONKOLOGII IM. MARII SKŁODOWSKIEJ-CURIE

      Medisinsk engroshandel

      URZĄDZENIA MEDYCZNE

      WIELKOPOLSKIE CENTRUM ONKOLOGII IM. MARII SKŁODOWSKIEJ-CURIE potrzebuje dostawy urządzeń medycznych w Poznaniu. Czas trwania umowy wynosi 6 tygodni. Medtronic Poland Sp. z o. o. oraz Devicor Medical Poland Sp. z o. o. mają dziś podobną umowę.

      CompetitionOct 5, 2026
      Nov 13, 2026(33 days)

    • Sykehusinnkjøp Hf

      Medisinsk og laboratorieutstyr

      NGS sekvenseringsplattform til avd. for patologi ved St. Olavs hospital HF

      Sykehusinnkjøp Hf planlegger anskaffelsen av en helautomatisert NGS-sekvenseringsplattform for avdeling for patologi ved St. Olavs hospital HF, som skal utvide og videreutvikle dagens analysekapasitet for klinisk diagnostikk av DNA og RNA fra FFPE-prøver og ctDNA. Løsningen skal være en samlet plattform som håndterer hele prosessen fra bibliotekspreparering til sekvensering, bioinformatisk analyse og rapportering, og skal være tilgjengelig med CE-IVD/IVDR-godkjente paneler der dette foreligger. Thermo Fisher Diagnostics AS har sannsynligvis kontrakten i dag.

      PlanningOct 8, 2026
      Feb 1, 2027(113 days)
      NOK 0